The role of SEVs in the promoting and treating liver fibrosis-MASP-1-enriched SEVs promote liver fibrosis while MSCs’ SEVs treating it
DOI:
https://doi.org/10.61173/bwkdfe08Keywords:
Liver fibrosis, HSCs, exosomes, MSCsAbstract
Liver fibrosis is a chronic severe liver disease. One prominent feature of liver fibrosis is the activated Hepatic stellate
cell. Across all the therapeutic tools for liver fibrosis, Mesenchymal stromal cells are widely studied and used. The
MSCs treat liver fibrosis by secreting cargo. One is an extracellular vesicle called an exosome containing proteins and
other secrets. As the critical role of exosomes in the cell’s communication and interchange of substances, more research
is reported. Five types of exosomes from different sources that each have different roles in either promoting or inhibiting
liver fibrosis are reviewed.
References
[1] Théry, C.; Zitvogel, L.; Amigorena, S. (2002) Exosomes: Composition, biogenesis and function. Nat. Rev. Immunol. 2: 569–579.
[2] Schorey, J.S.; Cheng, Y.; Singh, P.P.; Smith, V.L. (2015) Exosomes and other extracellular vesicles in host-pathogen interactions. EMBO Rep. 16: 24–43.
[3] Kolesova, O., Vanaga, I., Laivacuma, S., Derovs, A., Kolesovs, A., Radzina, M., Platkajis, A., Eglite, J., Hagina, E., Arutjunana, S., Putrins, D., Storozenko, J., Rozentale, B. and Viksna, L., (2021). Intriguing findings of liver fibrosis following COVID-19. BMC Gastroenterology, 21(1).
[4] Asrani, S.K.; Devarbhavi, H.; Eaton, J.; Kamath, P.S. (2019), Burden of liver diseases in the world. J. Hepatol. 70:151–171.
[5] Ekpanyapong, S.; Reddy, K.R. (2019),Hepatitis C virus therapy in advanced liver disease: Outcomes and challenges. United Eur. Gastroenterol. J. 7: 642–650.
[6] Tsuchida, T.; Friedman, S.L. (2017), Mechanisms of hepatic stellate cell activation. Nat. Rev. Gastroenterol. Hepatol. 14:397–411.
[7] Elpek, G.O. (2014), Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. World J. Gastroenterol. 20:7260–7276.
[8] Sebastiani, G.; Gkouvatsos, K.; Pantopoulos, K. (2014) Chronic hepatitis C and liver fibrosis. World J. Gastroenterol. 20:11033–11053.
[9] Friedman, S.L. (2008),Mechanisms of Hepatic Fibrogenesis. Gastroenterology. 134:1655–1669.
[10] Friedman, S.L. (2004), Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Nat. Clin. Pr. Gastroenterol. Hepatol. 1:98–105.
[11] Marcellin, P.; Kutala, B.K. (2018), Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening. Liver Int. Off. J. Int. Assoc. Study Liver. 38:2–6.
[12] Terai, S. & Tsuchiya, A. (2017). Status of and candidates for cell therapy in liver cirrhosis: overcoming the “point of no return” in advanced liver cirrhosis. J. Gastroenterol. 52:129–140.
[13] Tsuchiya, A. et al. (2017) Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases. Inflamm. Regen. (37) 16.
[14] Phinney D.G. Pittenger M.F. (2017) Concise review: MSC- derived exosomes for cell-free therapy. Stem Cells. 35(4):851-
[15] Keshtkar S. Azarpira N. Ghahremani M.H. (2018), Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res. Ther. 9: 63
[16] Feng Y. Huang W. Wani M. Yu X. Ashraf M. (2014), Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS ONE. 9: e88685
[17] Kim, J., Lee, C., Shin, Y., Wang, S., Han, J., Kim, M., Kim, J., Shin, S., Lee, B., Kim, T. and Jung, Y., (2021). sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486- 5p. Molecular Therapy, 29(4):1471-1486.
[18] Cho, K. A., Lee, H. J., Jeong, H., Kim, M., Jung, S. Y., Park, H. S., ... & Kim, H. S. (2019). Tonsil-derived stem cells as a new source of adult stem cells. World Journal of Stem Cells, 11(8):506.
[19] Park, M., Kim, Y. H., Woo, S. Y., Lee, H. J., Yu, Y., & Kim, H. S. (2015), Tonsil-derived mesenchymal stem cells ameliorate CCl4-induced liver fibrosis in mice via autophagy activation. Sci Rep. 5: 8616.
[20] Zhang, J., Li, S., Li, L., Li, M., Guo, C., Yao, J., & Mi, S. (2015). Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics, proteomics & bioinformatics, 13(1):17- 24. Dean&Francis
[21] Ma ZG, Lv XD, Zhan LL, Chen L, Zou QY, Xiang JQ, Qin JL, Zhang WW, Zeng ZJ, Jin H, et al. (2016), Human urokinasetype plasminogen activator gene-modified bone marrow-derived mesenchymal stem cells attenuate liver fibrosis in rats by downregulating the Wnt signaling pathway. World J Gastroenterol. 22(6):2092–103.
[22] Rong, X., Liu, J., Yao, X. et al. (2019), Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway. Stem Cell Res Ther 10(1):98.
[23] Menke J, Iwata Y, Rabacal WA, Basu R, Yeung YG, et al. (2009) CSF-1 signals directly to renal tubular epithelial cells to mediate repair in mice. J Clin Invest 119: 2330-2342.
[24] Morimoto H, Takahashi M, Shiba Y, Izawa A, Ise H, Hongo M, et al. (2007), Bone marrow-derived CXCR4+ cells mobilized by macrophage colony-stimulating factor participate in the reduction of infarct area and improvement of cardiac remodeling after myocardial infarction in mice. Am J Pathol 171: 755-766.
[25] López-García L, Castro-Manrreza ME. (2021), TNF-α and IFN-γ Participate in Improving the Immunoregulatory Capacity of Mesenchymal Stem/Stromal Cells: Importance of Cell-Cell Contact and Extracellular Vesicles. Int J Mol Sci. 22(17):9531.
[26] Takeuchi, S., Tsuchiya, A., Iwasawa, T. et al. (2021). Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis. npj Regen Med 19(6)
[27] Fallowfield, J. A., Mizuno, M., Kendall, T. J., Constandinou, C. M., Benyon, R. C., Duffield, J. S., & Iredale, J. P. (2007). Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. Journal of immunology Baltimore, Md. 178(8):5288–5295.
[28] Seo W, Eun HS, Kim SY, Yi HS, Lee YS, Park SH, Jang MJ, et al. (2016), Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by γδ T cells in liver fibrosis. Hepatology 64:616-631
[29] Hernández-Gea V, Ghiassi-Nejad Z, Rozenfeld R, Gordon R, Fiel MI, Yue Z, Czaja MJ, et al. (2012), Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology 142:938-946.
[30] Sun M, Tan L, Hu M. (2021), The role of autophagy in hepatic fibrosis. Am J Transl Res 13:5747- 5757.
[31] Gao J, Wei B, de Assuncao TM, Liu Z, Hu X, Ibrahim S, Cooper SA, et al. (2020), Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis. J Hepatol 73:1144- 1154.
[32] Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, et al. (2010), Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 12:19-30; sup pp 11-13.
[33] Liu, X., Tan, S., Liu, H., Jiang, J., Wang, X., Li, L., & Wu, B. (2022). Hepatocyte-derived MASP1-enriched small extracellular vesicles activate HSCs to promote liver fibrosis. Hepatology (Baltimore, Md.). https://doi.org/10.1002/hep.32662
[34] Mastrolia, I., Foppiani, E. M., Murgia, A., Candini, O., Samarelli, A. V., Grisendi, G., ... & Dominici, M. (2019). Challenges in clinical development of mesenchymal stromal/stem cells: concise review. Stem cells translational medicine, 8(11):1135-1148.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
